Matches in SemOpenAlex for { <https://semopenalex.org/work/W3162188907> ?p ?o ?g. }
- W3162188907 endingPage "571" @default.
- W3162188907 startingPage "571" @default.
- W3162188907 abstract "This research aimed to produce new 1-[(aryl)(3-amino-5-oxopyrazolidin-4-ylidene) methyl]-2-oxo-1,2-dihydroquinoline-3-carboxylic acid derivatives and check their anticancer effect against the breast cancer MCF-7 cell line. The 2-oxo-1,2-dihydroquinoline-3-carboxylic acid (4) compound was obtained by hydrolyzing ethyl 2-oxo-1,2-dihydroquinoline-3-carboxylate (2) with thiourea and anhydrous potassium carbonate ethanol, which was then treated with ethyl 3-substituted 2-cyanoacrylates (6) in the presence of triethylamine in diethyl formamide to give 1-[2-(ethoxy)carbonyl-2-cyano-1-arylvinyl]-2-oxo-1,2-dihydroquinoline-3-carboxylic (7a,d). Cyclization of compound 7 with hydrazine hydrate ethanol inferred the association of 1-[(aryl)(3 amino-5-oxopyrazolidin-4-ylidene)methyl-2-oxo-1,2-dihydroquinol-3-carboxylates (8a,d). Spectroscopic and micro-analytical techniques such as IR, NMR, and elemental analysis were used to validate the structure of the synthesized organic compounds. The anticancer effects of the synthesized compounds 7a–d and 8a–d were tested by using the MTT assay on the MCF-7 cell line. When compared to the reference compound Dox, the compounds 7b,c and 8a–c demonstrated strong anticancer activity against the MCF-7 cell line. The anticancer effects of the synthesized compounds 7a–d and 8a–d were tested against the MCF-7 cell line, using MTT assay. The compounds 7b,c and 8a–c showed significant anticancer activity compared to the reference compound Dox against the MCF-7 cell line." @default.
- W3162188907 created "2021-05-24" @default.
- W3162188907 creator A5011323623 @default.
- W3162188907 creator A5021464185 @default.
- W3162188907 creator A5039651839 @default.
- W3162188907 creator A5049678560 @default.
- W3162188907 creator A5056934831 @default.
- W3162188907 creator A5073366954 @default.
- W3162188907 date "2021-05-20" @default.
- W3162188907 modified "2023-10-13" @default.
- W3162188907 title "Synthesis of 1-[(Aryl)(3-amino-5-oxopyrazolidin-4-ylidene) methyl]-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid Derivatives and Their Breast Anticancer Activity" @default.
- W3162188907 cites W137915467 @default.
- W3162188907 cites W1963664975 @default.
- W3162188907 cites W1970523525 @default.
- W3162188907 cites W1972963629 @default.
- W3162188907 cites W2004211419 @default.
- W3162188907 cites W2004592535 @default.
- W3162188907 cites W2008201126 @default.
- W3162188907 cites W2013686434 @default.
- W3162188907 cites W2030145184 @default.
- W3162188907 cites W2038696352 @default.
- W3162188907 cites W2040668518 @default.
- W3162188907 cites W2042594051 @default.
- W3162188907 cites W2043277700 @default.
- W3162188907 cites W2057555162 @default.
- W3162188907 cites W2067021997 @default.
- W3162188907 cites W2078027546 @default.
- W3162188907 cites W2091150082 @default.
- W3162188907 cites W2094115819 @default.
- W3162188907 cites W2102169774 @default.
- W3162188907 cites W2135619784 @default.
- W3162188907 cites W2146161878 @default.
- W3162188907 cites W2175781917 @default.
- W3162188907 cites W2407040666 @default.
- W3162188907 cites W2541064047 @default.
- W3162188907 cites W2824569982 @default.
- W3162188907 cites W2900545929 @default.
- W3162188907 cites W2975697680 @default.
- W3162188907 cites W3037410604 @default.
- W3162188907 cites W3082158254 @default.
- W3162188907 doi "https://doi.org/10.3390/cryst11050571" @default.
- W3162188907 hasPublicationYear "2021" @default.
- W3162188907 type Work @default.
- W3162188907 sameAs 3162188907 @default.
- W3162188907 citedByCount "4" @default.
- W3162188907 countsByYear W31621889072022 @default.
- W3162188907 countsByYear W31621889072023 @default.
- W3162188907 crossrefType "journal-article" @default.
- W3162188907 hasAuthorship W3162188907A5011323623 @default.
- W3162188907 hasAuthorship W3162188907A5021464185 @default.
- W3162188907 hasAuthorship W3162188907A5039651839 @default.
- W3162188907 hasAuthorship W3162188907A5049678560 @default.
- W3162188907 hasAuthorship W3162188907A5056934831 @default.
- W3162188907 hasAuthorship W3162188907A5073366954 @default.
- W3162188907 hasBestOaLocation W31621889071 @default.
- W3162188907 hasConcept C155647269 @default.
- W3162188907 hasConcept C178790620 @default.
- W3162188907 hasConcept C185592680 @default.
- W3162188907 hasConcept C2779074116 @default.
- W3162188907 hasConcept C2780161600 @default.
- W3162188907 hasConcept C2780263894 @default.
- W3162188907 hasConcept C2780538656 @default.
- W3162188907 hasConcept C2780783641 @default.
- W3162188907 hasConcept C2781076698 @default.
- W3162188907 hasConcept C2781283055 @default.
- W3162188907 hasConcept C55493867 @default.
- W3162188907 hasConcept C62112901 @default.
- W3162188907 hasConcept C71240020 @default.
- W3162188907 hasConceptScore W3162188907C155647269 @default.
- W3162188907 hasConceptScore W3162188907C178790620 @default.
- W3162188907 hasConceptScore W3162188907C185592680 @default.
- W3162188907 hasConceptScore W3162188907C2779074116 @default.
- W3162188907 hasConceptScore W3162188907C2780161600 @default.
- W3162188907 hasConceptScore W3162188907C2780263894 @default.
- W3162188907 hasConceptScore W3162188907C2780538656 @default.
- W3162188907 hasConceptScore W3162188907C2780783641 @default.
- W3162188907 hasConceptScore W3162188907C2781076698 @default.
- W3162188907 hasConceptScore W3162188907C2781283055 @default.
- W3162188907 hasConceptScore W3162188907C55493867 @default.
- W3162188907 hasConceptScore W3162188907C62112901 @default.
- W3162188907 hasConceptScore W3162188907C71240020 @default.
- W3162188907 hasIssue "5" @default.
- W3162188907 hasLocation W31621889071 @default.
- W3162188907 hasOpenAccess W3162188907 @default.
- W3162188907 hasPrimaryLocation W31621889071 @default.
- W3162188907 hasRelatedWork W1967245927 @default.
- W3162188907 hasRelatedWork W2340738205 @default.
- W3162188907 hasRelatedWork W2352163101 @default.
- W3162188907 hasRelatedWork W2354405638 @default.
- W3162188907 hasRelatedWork W2364721921 @default.
- W3162188907 hasRelatedWork W2374074261 @default.
- W3162188907 hasRelatedWork W2418519479 @default.
- W3162188907 hasRelatedWork W2514374981 @default.
- W3162188907 hasRelatedWork W2905128512 @default.
- W3162188907 hasRelatedWork W4225388239 @default.
- W3162188907 hasVolume "11" @default.
- W3162188907 isParatext "false" @default.
- W3162188907 isRetracted "false" @default.